Below are significant results linked to the largest annual diabetes congress that just concluded which highlight exciting advances, many of which were...Read More
Canadian business executive, Tom Gaglardi, President of Northland Properties Corporation and owner of the Dallas Stars, presented a generous $3M gift to JDRF Canada to support type 1 diabetes research in the areas of encapsulation, and beta cell replacement and regeneration.
Building a strong partnership to accelerate type 1 diabetes clinical trials research
JDRF & Lilly Canada fund UBC research that could allow people with type 1 diabetes to produce their own insulin
JDRF and Lilly Canada have awarded a post-doctoral fellowship grant of CAN$60,000 to promising researcher Dr. Cara Ellis, a post-doctoral fellow from the University of British Columbia (UBC).
$550,000 raised to accelerate funding for type 1 diabetes research
JDRF and the University of Toronto support research into a skin patch to prevent common, life-threatening risk of T1D
TORONTO – October 20, 2016, JDRF and the University of Toronto are pleased to announce a $400,000 (USD) research grant to support the development of a skin [transdermal] patch to prevent hypoglycemia – a common, potentially life-threatening, risk for people living with type 1 diabet...
JDRF and the University of Toronto are supporting research that will help improve islet transplantation and make the procedure more widely available for patients living with type 1 diabetes (T1D).
JDRF Canada awards $466,450 (USD) to Dr. Ahmad Haidar and his team at McGill University to improve the artificial pancreas system
JDRF Canada awards new research grant to Dr. Kieffer to explore new options for stem cell derived transplants for diabetes patients